Associated Papers
Next-generation Sequencing and Other Second Tier Tests in Newborn Screening for (X-linked) Agammaglobulinemia.
Blom M et al.
Journal of Clinical Immunology, 2025
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
CoDIAC: A comprehensive approach for interaction analysis reveals novel insights into SH2 domain function and regulation.
Kandoor A et al.
Biorxiv : the Preprint Server for Biology, 2025
Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms.
Duarte DP et al.
Nature Communications, 2020
The Src module: an ancient scaffold in the evolution of cytoplasmic tyrosine kinases.
Shah NH et al.
Critical Reviews in Biochemistry and Molecular Biology, 2018
X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia.
Hoshino A et al.
Journal of Clinical Immunology, 2015
Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.
Ryu GM et al.
Nucleic Acids Research, 2009
Genome wide analysis of pathogenic SH2 domain mutations.
Lappalainen I et al.
Proteins, 2008
Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton's tyrosine kinase.
Huang KC et al.
Journal of Biomolecular Nmr, 2006
Bruton tyrosine kinase gene mutations in Argentina.
Danielian S et al.
Human Mutation, 2003
Phosphorylation of Bruton's tyrosine kinase by c-Abl.
Bäckesjö CM et al.
Biochemical and Biophysical Research Communications, 2002
Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Vihinen M et al.
Frontiers in Bioscience : a Journal and Virtual Library, 2000
Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
Tzeng SR et al.
Protein Science : a Publication of the Protein Society, 2000
Structure-function effects in primary immunodeficiencies.
Korpi M et al.
Scandinavian Journal of Immunology, 2000
Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
Mattsson PT et al.
Journal of Immunology (baltimore, Md. : 1950), 2000
Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia.
Vorechovský I et al.
Human Mutation, 1997
Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
Schuster V et al.
American Journal of Medical Genetics, 1996